Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-10-000296
Filing Date
2010-03-09
Accepted
2010-03-09 16:45:45
Documents
14
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K appy_10k.htm 10-K 1427329
2 EXHIBIT 10.1.1 ex10x1x1.htm EX-10.1.1 8168
3 EXHIBIT 10.1.2 ex10x1x2.htm EX-10.1.2 8376
4 EXHIBIT 10.4.1 ex10x4x1.htm EX-10.4.1 43699
5 EXHIBIT 10.6 ex10x6.htm EX-10.6 68008
6 EXHIBIT 10.12 ex10x12.htm EX-10.12 61415
7 EXHIBIT 10.13 ex10x13.htm EX-10.13 61458
8 EXHIBIT 10.14 ex10x14.htm EX-10.14 72318
9 EXHIBIT 10.15 ex10x15.htm EX-10.15 7320
10 EXHIBIT 23 ex23x1.htm EX-23 4264
11 EXHIBIT 31.1 ex31x1.htm EX-31.1 18046
12 EXHIBIT 31.2 ex31x2.htm EX-31.2 18296
13 EXHIBIT 32 ex32.htm EX-32 11962
14 performance3.jpg GRAPHIC 33321
  Complete submission text file 0001079973-10-000296.txt   1858189
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 10667617
SIC: 2835 In Vitro & In Vivo Diagnostic Substances